Table 3 Demographics and Clinical Data of MRSA positive patients
Characteristics | HCWcf | Non-HCWcf | P value | ||
|---|---|---|---|---|---|
No.a | No.a | ||||
Male, n (%) | 10 | 5 (50) | 40 | 25 (63) | 0.494 |
Age (years), median (IQR) | 10 | 28 (26–37.5) | 39 | 22 (19–27) | 0.02 |
FEV1 % predicted, median (IQR) | 10 | 72.4 (62.2–90.9) | 36 | 48.7 (33.2–64.8) | 0.009 |
Pancreatic insufficient, n (%) | 10 | 7 (70) | 40 | 38 (95) | 0.048 |
P. aeruginosa infection, n (%) | 10 | 7 (70) | 40 | 37 (93) | 0.086 |
Hospitalisations in 2 years prior, median (IQR) | 9 | 3 (1–4) | 32 | 4 (2–6) | 0.23 |
Hospital days in 2 years prior, median (IQR) | 9 | 27 (4–37) | 31 | 49 (19–76) | 0.177 |
Peripheral colonisation, n (%) | 9 | 2 (22) | 33 | 9 (27) | 1.0 |
mrMRSA, n (%) | 10 | 5 (50) | 40 | 30 (75) | 0.143 |